Tuesday, March 18, 2014
(Undated) -- GlaxoSmithKline will be hiring doctors to educate their colleagues about the company's drugs rather than using external speakers. It's another change the pharmaceutical company is making to its marketing practices following a record fraud settlement in the U.S. In 2012 Glaxo agreed to pay three-billion dollars to settle allegations it illegally promoted two popular anti-depressants. Additionally, the settlement covered the company's failure to report safety data on its Avandia diabetes drug. Glaxo also plans to stop paying doctors for giving speeches and attending medical conferences by early 2016.